About Adlyfe
Adlyfe is a company based in Rockville (United States) founded in 2003. It operates as a B2B. Adlyfe has raised $8.3 million across 2 funding rounds from investors including Canaan, Burrill and Company and Maryland Department of Commerce. The company has 1 employees as of December 31, 2022. Adlyfe operates in a competitive market with competitors including Cytox, ADx NeuroSciences, Amprion, PeopleBio R&D and Durin Technologies, among others.
- Headquarter Rockville, United States
- Employees 1 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Adlyfe
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.3 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series B
Feb 20, 2013
-
Investors
Canaan
& 2 more
-
Employee Count
1
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Adlyfe
Adlyfe has successfully raised a total of $8.3M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Adlyfe
Adlyfe has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Canaan, Burrill and Company and Maryland Department of Commerce.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
Economic development services are provided by Maryland Department of Commerce.
|
Locked | Locked | Locked | |
|
Multi-category products are listed on an online B2B platform.
|
Locked | Locked | Locked |
Investor details for Adlyfe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adlyfe
Investment portfolio details for Adlyfe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adlyfe
Detailed financials for Adlyfe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adlyfe Comparisons
Peer comparison for Adlyfe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adlyfe
Adlyfe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytox, ADx NeuroSciences, Amprion, PeopleBio R&D and Durin Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| Locked | Locked | Locked |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Developer of the diagnostic test for neurodegenerative diseases
|
Detailed competitors of Adlyfe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adlyfe
Complete news archive for Adlyfe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adlyfe
Adlyfe was founded in 2003 and raised its 1st funding round 3 years after it was founded.
Adlyfe is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Adlyfe is a funded company, having raised a total of $8.3M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Adlyfe is 1.
Adlyfe, founded in 2003 in Rockville, United States, focuses on providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and biomarker development. Develops biomarkers and diagnostic tests for amyloid-related diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Adlyfe's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.
Adlyfe has 3 investors. Key investors include Canaan, Burrill and Company, and Maryland Department of Commerce.